Lite Strategy

Clinical-stage pharmaceutical company(NASDAQ: LITS)

Über Lite Strategy

Gegründet2018
Lite Strategy, Inc.(NASDAQ: LITS) is a clinical-stage pharmaceutical company headquartered in San Diego, California, USA, focused on developing innovative therapies that primarily combat drug resistance mechanisms in cancer, aiming to improve patient outcomes in combination with standard treatments.
Community
Twitter
Website
Tags
Publicly listed company
Crypto Stocks

Trend der heißen Indexänderung

Details zum Fundrasing

Post-IPO(2025-07-21)
Menge$100,00M
Bewertung--